The Connectivity Map Links Iron Regulatory Protein-1–Mediated Inhibition of Hypoxia-Inducible Factor-2a Translation to the Anti-inflammatory 15-deoxy-Δ12,14-Prostaglandin J2
Tóm tắt
Hypoxia-inducible factors 1 and 2 (HIF1 and HIF2) are heterodimeric transcription factors consisting of α regulatory subunits and a constitutively expressed β subunit. The expression of α regulatory subunits is promoted by hypoxia, cancer-associated mutations, and inflammatory cytokines. Thus, HIF1 and HIF2 provide a molecular link between cancer and inflammation. We have recently identified novel small molecules that selectively inhibit translation of the HIF2a message and thereby powerfully inhibit the expression of HIF2a target genes. We report here that Connectivity Map analysis links three of these compounds to the anti-inflammatory cytokine 15-deoxy-Δ12,14-prostaglandin J2 (PGJ2). As with our identified compounds, PGJ2 inhibits translation of the HIF2a message in a mammalian target of rapamycin–independent manner by promoting the binding of iron regulatory protein-1 (IRP1) to a noncanonical iron responsive element (IRE) embedded within the 5′-untranslated region of the HIF2a message. The IRE is necessary and sufficient for mediating the effect. Mutation of the IRE sequence, or downregulation of IRP1 expression, blocks the effect of PGJ2 on HIF2a translation. This is the first report of an endogenous natural molecule regulating HIF2a translation, and it suggests that part of the anti-inflammatory and putative antineoplastic effects of PGJ2 may be mediated through inhibition of HIF2a within tumor epithelial cells themselves and/or mesenchymal cells of the tumor microenvironment. Cancer Res; 70(8); 3071–9. ©2010 AACR.
Từ khóa
Tài liệu tham khảo
Iliopoulos, 2006, Molecular biology of renal cell cancer and the identification of therapeutic targets, J Clin Oncol, 24, 5593, 10.1200/JCO.2006.08.8948
Kondo, 2002, Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein, Cancer Cell, 1, 237, 10.1016/S1535-6108(02)00043-0
Kondo, 2003, Inhibition of HIF2α is sufficient to suppress pVHL-defective tumor growth, PLoS Biol, 1, 83, 10.1371/journal.pbio.0000083
Zimmer, 2004, Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL−/− tumors, Mol Cancer Res, 2, 89, 10.1158/1541-7786.89.2.2
Zhang, 2007, Inhibition of VEGF expression by targeting HIF-1α with small interference RNA in human RPE cells, Ophthalmologica, 221, 411, 10.1159/000107502
Cramer, 2003, HIF-1α is essential for myeloid cell-mediated inflammation, Cell, 112, 645, 10.1016/S0092-8674(03)00154-5
Rius, 2008, NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α, Nature, 453, 807, 10.1038/nature06905
Zimmer, 2008, Small-molecule inhibitors of HIF-2a translation link its 5′UTR iron-responsive element to oxygen sensing, Mol Cell, 32, 838, 10.1016/j.molcel.2008.12.004
Sanchez, 2007, Iron-regulatory proteins limit hypoxia-inducible factor-2α expression in iron deficiency, Nat Struct Mol Biol, 14, 420, 10.1038/nsmb1222
Kim, 2006, 15-deoxy-Δ12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors, Biochem Pharmacol, 72, 1516, 10.1016/j.bcp.2006.07.030
Rajakariar, 2007, Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyΔ12-14 PGJ2, Proc Natl Acad Sci U S A, 104, 20979, 10.1073/pnas.0707394104
Gilroy, 2003, Inducible cyclooxygenase-derived 15-deoxyΔ12-14 PGJ2 brings about acute inflammatory resolution in rat pleurisy by inducing neutrophil and macrophage apoptosis, FASEB J, 17, 2269, 10.1096/fj.02-1162fje
Bell-Parikh, 2003, Biosynthesis of 15-deoxy-Δ12,14-PGJ2 and the ligation of PPARγ, J Clin Invest, 112, 945, 10.1172/JCI200318012
Sambrook, 1989, Molecular cloning: a laboratory manual
Lamb, 2006, The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease, Science, 313, 1929, 10.1126/science.1132939
Lynch, 2005, hnRNP K binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes to neoplastic transformation, Mol Cell Biol, 25, 6436, 10.1128/MCB.25.15.6436-6453.2005
Wang, 2002, The prolyl 4-hydroxylase inhibitor ethyl-3,4-dihydroxybenzoate generates effective iron deficiency in cultured cells, FEBS Lett, 529, 309, 10.1016/S0014-5793(02)03389-6
Hudson, 2002, Regulation of hypoxia-inducible factor 1α expression and function by the mammalian target of rapamycin, Mol Cell Biol, 22, 7004, 10.1128/MCB.22.20.7004-7014.2002
Majumder, 2004, mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways, Nat Med, 10, 594, 10.1038/nm1052
Brugarolas, 2004, Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex, Genes Dev, 18, 2893, 10.1101/gad.1256804
Yang, 2004, A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A, Mol Cell Biol, 24, 3894, 10.1128/MCB.24.9.3894-3906.2004
Rouault, 2006, The role of iron regulatory proteins in mammalian iron homeostasis and disease, Nat Chem Biol, 2, 406, 10.1038/nchembio807
Ke, 1998, Loops and bulge/loops in iron-responsive element isoforms influence iron regulatory protein binding. Fine-tuning of mRNA regulation?, J Biol Chem, 273, 23637, 10.1074/jbc.273.37.23637
Toschi, 2008, Differential dependence of hypoxia-inducible factors 1α and 2α on mTORC1 and mTORC2, J Biol Chem, 283, 34495, 10.1074/jbc.C800170200
Liu, 2002, Prostaglandin E2 induces hypoxia-inducible factor-1α stabilization and nuclear localization in a human prostate cancer cell line, J Biol Chem, 277, 50081, 10.1074/jbc.M201095200
Fukuda, 2003, Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1, Cancer Res, 63, 2330
Pai, 2002, Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy, Nat Med, 8, 289, 10.1038/nm0302-289
Wang, 2005, Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade, Cancer Res, 65, 1822, 10.1158/0008-5472.CAN-04-3671
Wang, 2004, Prostaglandin E2 promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor δ, Cancer Cell, 6, 285, 10.1016/j.ccr.2004.08.011
Sonoshita, 2001, Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Δ716) knockout mice, Nat Med, 7, 1048, 10.1038/nm0901-1048
Olmos, 2009, 15-Deoxy-Δ12,14-prostaglandin-J2 reveals a new pVHL-independent, lysosomal-dependent mechanism of HIF-1α degradation, Cell Mol Life Sci, 66, 2167, 10.1007/s00018-009-0039-x
Skuli, 2006, Activation of RhoB by hypoxia controls hypoxia-inducible factor-1α stabilization through glycogen synthase kinase-3 in U87 glioblastoma cells, Cancer Res, 66, 482, 10.1158/0008-5472.CAN-05-2299
Park, 2007, Hematopoietic prostaglandin D synthase suppresses intestinal adenomas in ApcMin/+ mice, Cancer Res, 67, 881, 10.1158/0008-5472.CAN-05-3767
Kim, 2007, Anti-inflammatory lipid mediator 15d-PGJ2 inhibits translation through inactivation of eIF4A, EMBO J, 26, 5020, 10.1038/sj.emboj.7601920
Murakawa, 1987, Iron deficiency and neutrophil function: different rates of correction of the depressions in oxidative burst and myeloperoxidase activity after iron treatment, Blood, 69, 1464, 10.1182/blood.V69.5.1464.1464
Fleming, 2008, Iron and inflammation: cross-talk between pathways regulating hepcidin, J Mol Med, 86, 491, 10.1007/s00109-008-0349-8